BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2016 12:40:00 AM | Browse: 1125 | Download: 2275
 |
Received |
|
2016-06-21 10:50 |
|
Peer-Review Started |
|
2016-06-22 09:04 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-07-29 18:25 |
|
Revised |
|
2016-08-25 23:34 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-09-21 17:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-09-28 19:15 |
|
Articles in Press |
|
2016-09-28 19:15 |
|
Edit the Manuscript by Language Editor |
|
2016-10-26 16:05 |
|
Typeset the Manuscript |
|
2016-11-25 16:47 |
|
Publish the Manuscript Online |
|
2016-12-13 00:40 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Ting He, Xiao-Guang Ye and Xiao-Yuan Zhou |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Xiao-Guang Ye, Department of In fectious Diseases, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, Guangdong Province, China. yexiaoguang@126.com |
| Key Words |
Chronic hepatitis B; Entecavir; pegylated interferon-α-2a; Sequential therapy; Effect |
| Core Tip |
It is necessary to achieve termination safely with minimal risk of long-term resistance in nucleos(t)ide analog (NA)-treated chronic hepatitis B (CHB) patients. We studied NA-treated CHB patients who stopped NAs safely and achieved sustained virological and immunological responses after treatment. We clarified the efficacy and safety of sequential 48-wk pegylated interferon-α-2a (PegIFNα-2a) in NA-treated CHB patients during and after treatment termination. Patients were selected based on the initial serum hepatitis B surface antigen (HBsAg) level. PegIFNα-2a was adjusted based on HBsAg levels at 24 wk of treatment, an important and significant factor in achieving treatment termination safely with immune control. |
| Publish Date |
2016-12-13 00:40 |
| Citation |
He LT, Ye XG, Zhou XY. Effect of switching from treatment with nucleos(t)ide analogues to pegylated interferon -2a on virological and serological response in chronic hepatitis B patients. World J Gastroenterol 2016; 22(46): 10210-10218 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i46/10210.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i46.10210 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
